Clinical Trials in Boston

Showing 3101-3120 of 8,503 trials

Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients With ALS

NCT02017912

This is a multi-center, randomized, double blind, placebo controlled study to evaluate the safety and efficacy of autologous (self) transplantation of Neurotrophic factors-secreting Mesenchymal Stromal Cells (MSC-NTF, NurOwn™) in patients with ALS . MSC-NTF cells are a novel cell-therapeutic approach which is expected to effectively deliver Neurotrophic factors, which are potent survival factors for neurons, directly to the site of damage.

Amyotrophic Lateral Sclerosis (ALS)

Brainstorm-Cell Therapeutics48 participantsStarted May 2014

Boston, Massachusetts, United States • Worcester, Massachusetts, United States • Rochester, Minnesota, United States

TERMINATEDPhase 2< 1 mile

PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer

NCT04404361

This is a Phase 2 randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of pacritinib in hospitalized patients with severe COVID-19 with or without cancer.

COVID19COVID-19COVID

CTI BioPharma200 participantsStarted May 2020

Orange, California, United States • Jacksonville, Florida, United States • Atlanta, Georgia, United States +18 more locations

Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients With ALS

PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer

Find Trials by Condition in Boston

Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma

Rivet PVS Therapy in Group 2 PH-HFpEF

THIS-WIC Vermont Breastfeeding Education Application Feasibility Study

South Carolina WIC Telehealth Solution

Telehealth Intervention Strategies for WIC (THIS-WIC)- Michigan

A Pharmacologic Study of CYC065, a Cyclin Dependent Kinase Inhibitor, in Patients With Advanced Cancers

Development and Evaluation of "Period Kits" for Adolescents With Intellectual and Developmental Disabilities

Evaluation of the Spiration® Valve System for Emphysema to Improve Lung Function

Safety and Pharmacokinetics of AT-007 in Healthy Subjects and in Adult Subjects With Classic Galactosemia

Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy

Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder for Subjects That Have Completed Participation in 331-201-00148

Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease

Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)

Substance Use Interventions for Truant Adolescents

(Revival) Study to Investigate the Efficacy and Safety of Alkaline Phosphatase in Patients With Sepsis-Associated AKI

Safety and Efficacy of Emixustat in Stargardt Disease

A Dose Escalation and Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7283420.

Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)